Keyword: GlaxoSmithKline (GSK)
News
18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
News
16.07.2012
- GlaxoSmithKline is expected to announce an agreement to acquire Human Genome Sciences for about $2.8 billion as soon as Monday, ending three months of its hostile pursuit of the U...
News
15.07.2012
- Europe's medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl...
News
07.07.2012
- Celgene is one of two companies discussing whether to bid for Human Genome Sciences, which seeks an alternative to a hostile offer by British drugmaker GlaxoSmithKline, a source...
News
03.07.2012
- GlaxoSmithKline agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare...
News
29.06.2012
- GlaxoSmithKline has once again extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until July 20 as a hostile stand-off with the U.S. biotech company...
News
19.06.2012
- The U.S. Supreme Court ruled on Monday that pharmaceutical companies do not have to pay overtime to their representatives who visit doctors' offices to promote their products, a...
News
15.06.2012
- U.S. biotech company Human Genome Sciences said on Friday it had set a bid date of July 16 for definitive offers to acquire the company and again urged hostile bidder...
